Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
sensitization
|
primary exposure to antigen
|
|
immediate phase
|
5-60 minutes
controlled by histamine and other mediators stored in granules of mast cells |
|
late phase
|
4-24 hours
controlled by eosinophils |
|
Sensitization phase
|
uptake of soluble Ag by APC
Ig-class switching of IgE est. of IgE+ memory B cells and memory T cells |
|
immediate phase
|
upon 2nd exposure
crosslinking of 2 or more IgE leads to degranulation of mast cells |
|
Late phase
|
involves Th2 cells
release IL-4, IL-13 Release IL-5, which stimulates eosinophils (from bone marrow to tissues) |
|
immunological hypersensitivities
|
lead to tissue damage
|
|
anaphylaxis
|
used to describe systemic immediate hypersensitivity
|
|
Type I hypersensitivity
|
aka immediate hypersensitivity
IgE degranulation of mast cells, basophils, eosinophils rxn occurs very fast often assoc. w/ autoimmune diseases Asthma, hayfever, anaphylaxis, food allergy |
|
Type II hypersensitivity
|
Cytotoxic hypersensitivity
involves IgG and complement causes inflammation in tissues, circulating Abs react w/ host cell surface assoc. with Goodpasture syndrome, Purpura/drug sensitivity, hemolytic disease of newborn (Rh-antigen of RBC), and Myasthenia Gravis |
|
Type III hypersensitivity
|
Immune complex hypersensitivity
involves circulating Ab-Ag complexes complexes fix complement to release anaphylatoxin C3a and C5a tissue deposition leads to tissue damage release of vasoactive amines from basophils and other inflammatory cells (neutrophils) assoc. w/ Serum sickness, Arthus rxn, systemic lupus erythematosus, and extrinsic allergic alveolitis |
|
Type IV hypersensitivity
|
Delayed hypersensitivity
assoc. w immune cells, not Abs mycobacteria, TB injection cytokines induce more TNF alpha, IL-1 and IL-6, which induces productions of chemokines chemokines attract macrophages and other T cells to lesions assoc. with delayed hypersens, contact hypersens, and TH2 responses |
|
Type V hypersensitivity
|
changes physiology
assoc. w/ Graves disease and Myasthenia gravis (can be Type V or Type II) |
|
CD19
|
coreceptor of BCR
specific marker of BCR |
|
CD 19 and CD21
|
B cell co-receptors needed for potent response/activation of B cells
|
|
CD 21
|
binds complement recptor C3b
|
|
B cell needs CD 19 and CD21
|
also needs CD4 T helper cells in order to create potent response
|
|
T helper cell role in B cell activation
|
Ag binds BCR=1st signal to B cell
Helper Th2 cell=delivers 2nd signal to B cell via CD40L and cytokines B cell proliferates and differentiates into plasma cells |
|
B cells develop in bone marrow
|
mature B cells migrate to lymph nodes via bloodstream
leave via efferent lymphatic vessel |